Provided by Tiger Fintech (Singapore) Pte. Ltd.

InMed Pharmaceuticals Inc

2.78
-0.1000-3.47%
Post-market: 2.77-0.0100-0.36%16:05 EDT
Volume:14.77K
Turnover:40.65K
Market Cap:3.36M
PE:-0.20
High:2.81
Open:2.75
Low:2.73
Close:2.88
Loading ...

BRIEF-InMed Pharmaceuticals Files For Offering Of 3 Million Common Shares By Selling Stockholder

Reuters
·
24 Dec 2024

InMed Pharmaceuticals Inc Files for Offering of 3 Mln Common Shares by Selling Stockholder - SEC Filing

THOMSON REUTERS
·
24 Dec 2024

InMed Pharmaceuticals’ 2024 AGM Results Announced

TIPRANKS
·
19 Dec 2024

InMed Announces Results of 2024 Annual General Meeting

Newsfile
·
19 Dec 2024

InMed Pharmaceuticals Secures $10 Million Equity Purchase Agreement

TIPRANKS
·
18 Dec 2024

InMed Enters Into Standby Equity Purchase Agreement

Newsfile
·
18 Dec 2024

InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System

Newsfile
·
19 Nov 2024

InMed Pharmaceuticals Yesterday Reported Q4 EPS $(2.17) Down From $(0.19) YoY, Sales $1.26M Up From $901.86K YoY

Benzinga
·
15 Nov 2024

InMed Pharmaceuticals Inc: Qtrly Loss per Share $2.17

THOMSON REUTERS
·
15 Nov 2024

InMed Pharmaceuticals Makes Progress on Alzheimer’s Drug

TIPRANKS
·
15 Nov 2024

InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

Newsfile
·
15 Nov 2024

InMed Pharmaceuticals Inc trading halted, news pending

TIPRANKS
·
14 Nov 2024

InMed Announces Share Consolidation to Satisfy Nasdaq Listing Rules

Newsfile
·
09 Nov 2024

InMed Pharmaceuticals to Consolidate Shares for Nasdaq Compliance

TIPRANKS
·
05 Nov 2024

InMed Pharmaceuticals Announces Decision by NASDAQ Hearings Panel to Grant Exception to Implement Share Consolidation to Satisfy NASDAQ Listing Rules

Newsfile
·
05 Nov 2024

InMed Pharmaceuticals’ New Alzheimer’s Treatment Patent

TIPRANKS
·
28 Oct 2024